Wang Ningxi, Song Li, Peng Yue, Wei Langqiu, Long Zhaofan, Wang Che, Liu Qiling, Shi Chuandao
School of Public Health, Shaanxi University of Chinese Medicine, Xianyang, China.
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Front Pharmacol. 2025 Aug 14;16:1633813. doi: 10.3389/fphar.2025.1633813. eCollection 2025.
Osteoporosis (OP), an age-related skeletal disorder characterized by reduced bone mass and deteriorated microarchitecture, and non-alcoholic fatty liver disease (NAFLD), a metabolic condition primarily driven by obesity and insulin resistance (with age as a modifying factor), were investigated in this study. We aimed to elucidate the correlation between OP and NAFLD-associated lipid metabolism, and determine the therapeutic effects and molecular mechanisms of Kangshujiangu granules (KSJG) on NAFLD pathogenesis.
Clinical study: 261 patients were stratified by OP T-scores into OP and non-OP groups. Bone density, lipid profiles, and liver function were analyzed for NAFLD-OP correlations. : 60 female SD rats were randomized into control, NAFLD-OP model, low/medium/high-dose KSJG, and Icariin (ICA) groups. Metabolic indicators and autophagy related proteins were evaluated. : FFA-induced hepatocytes were treated with Compound C, KSJG, or FF. Cells were divided into six groups: BSA control, FFA model, FFA + Compound C, FFA + KSJG, FFA + FF, and FFA + KSJG + Compound C. Lipid accumulation, metabolic markers, and autophagy proteins were analyzed.
Clinical findings: Osteoporosis prevalence exhibited age-dependent elevation. Age, BMI, TC, and TG as independent risk factors for OP ( < 0.05). results: KSJG granules significantly attenuated body weight, reduce liver wet weight and liver index; improve lipid accumulation and lipid metabolism disorders; increase autophagy levels in liver tissue, reduce the expression of p-Akt, p-mTOR and p-ULK1 (Ser757), and increase the expression of p-AMPK and p-ULK1 (Ser555) ( < 0.05). experiments:Both KSJG and FF significantly reduced FFA-induced TG, ALT, AST, and lipid droplet accumulation ( < 0.05). They upregulated LC3Ⅱ/LC3Ⅰ, Atg7, and Beclin 1 while downregulating p62. Additionally, KSJG and FF decreased p-mTOR and p-ULK1 (Ser757) but increased p-AMPK and p-ULK1 (Ser555),while Compound C could reverses this.
OP exhibited a negative correlation with lipid metabolism indexes of NAFLD. Bilateral ovariectomy (OVX) simultaneously induced OP and NAFLD, while KSJG granules ameliorated lipid dysregulation via autophagy modulation. KSJG granules enhanced autophagy activation through the AMPK/ULK1 (Ser555) pathway, thereby alleviating NAFLD-associated lipid metabolic disturbances.
骨质疏松症(OP)是一种与年龄相关的骨骼疾病,其特征为骨量减少和微结构恶化;非酒精性脂肪性肝病(NAFLD)是一种主要由肥胖和胰岛素抵抗(年龄为调节因素)驱动的代谢性疾病。本研究对这两种疾病进行了调查。我们旨在阐明OP与NAFLD相关脂质代谢之间的相关性,并确定抗shu健骨颗粒(KSJG)对NAFLD发病机制的治疗作用和分子机制。
临床研究:261例患者根据OP的T值分层为OP组和非OP组。分析骨密度、血脂谱和肝功能以探讨NAFLD与OP的相关性。实验研究:60只雌性SD大鼠随机分为对照组、NAFLD-OP模型组、低/中/高剂量KSJG组和淫羊藿苷(ICA)组。评估代谢指标和自噬相关蛋白。细胞实验:用化合物C、KSJG或FF处理游离脂肪酸(FFA)诱导的肝细胞。细胞分为六组:牛血清白蛋白(BSA)对照组、FFA模型组、FFA + 化合物C组、FFA + KSJG组、FFA + FF组和FFA + KSJG + 化合物C组。分析脂质积累、代谢标志物和自噬蛋白。
临床研究结果:骨质疏松症患病率呈年龄依赖性升高。年龄、体重指数(BMI)、总胆固醇(TC)和甘油三酯(TG)是OP的独立危险因素(P < 0.05)。实验研究结果:KSJG颗粒显著减轻体重,降低肝脏湿重和肝脏指数;改善脂质积累和脂质代谢紊乱;提高肝组织自噬水平,降低磷酸化蛋白激酶B(p-Akt)、磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)和磷酸化Unc-51样自噬激活激酶1(Ser757)(p-ULK1)的表达,并增加磷酸化腺苷酸活化蛋白激酶(p-AMPK)和p-ULK1(Ser555)的表达(P < 0.05)。细胞实验结果:KSJG和FF均显著降低FFA诱导的甘油三酯(TG)、谷丙转氨酶(ALT)、谷草转氨酶(AST)和脂滴积累(P < 0.05)。它们上调微管相关蛋白轻链3Ⅱ/微管相关蛋白轻链3Ⅰ(LC3Ⅱ/LC3Ⅰ)、自噬相关蛋白7(Atg7)和Beclin 1,同时下调p62。此外,KSJG和FF降低p-mTOR和p-ULK1(Ser757),但增加p-AMPK和p-ULK1(Ser555),而化合物C可逆转此作用。
OP与NAFLD的脂质代谢指标呈负相关。双侧卵巢切除术(OVX)同时诱导OP和NAFLD,而KSJG颗粒通过自噬调节改善脂质失调。KSJG颗粒通过AMPK/ULK1(Ser555)途径增强自噬激活,从而减轻NAFLD相关的脂质代谢紊乱。